• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CDI BLOOD PARAMETER MONITORING SYSTEM 500; MONITOR, BLOOD-GAS, ON-LINE, CARDIOPULMONARY BYPASS-CDI BPM SYSTEM 500

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION CDI BLOOD PARAMETER MONITORING SYSTEM 500; MONITOR, BLOOD-GAS, ON-LINE, CARDIOPULMONARY BYPASS-CDI BPM SYSTEM 500 Back to Search Results
Model Number 500AHCT
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/26/2021
Event Type  malfunction  
Event Description
It was reported that during set-up of the device for a cardiopulmonary bypass (cpb) procedure, the venous saturation stayed at 100% despite being adjusted to 70%.As a result, an alternate device was employed.The surgical procedure was completed successfully.There was no delay, no blood loss, nor adverse consequences to the patient.
 
Event Description
It was concluded that the reported issue occurred during use of the device for a cardiopulmonary bypass (cpb) procedure.Per clinical review: the manufacturer's clinical specialist spoke with the perfusionist regarding the incident the team had with the blood parameter monitor (bpm) during a cardiopulmonary bypass (cpb) procedure on (b)(6) 2021.The bpm passed the color chip test without issue.The team initiated cpb and the bpm venous saturation was reading 100% before and after the venous in-vivo calibration.The perfusionist did not exchange the unit out and continued the procedure without the correct reading.There was no delay in the continuation of the surgical procedure.There was no harm or blood loss due to the issue.
 
Manufacturer Narrative
The reported complaint was not confirmed.The service repair technician (srt) could not reproduce the issue.The monitor powered on and passed self-test and the arterial blood parameter monitor (bpm) passed intensity test.The hematocrit saturation (hsat) passed service mode testing.The unit operated to the manufacturer's specifications.The hsat was replaced to address the color chip errors received during laboratory analysis.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
 
Manufacturer Narrative
During laboratory analysis, the product surveillance technician (pst) did not observe the reported complaint.He powered up the monitor and the erasable electronically programmable read only memory (eeprom) had 15 recorded color chip failures.The pst powered the monitor up in service mode and the color chip test was performed two times, once as received and the second after cleaning.The first test, the ir1 channel failed product specification limit of +/- 12.5% with a value of 18.1%.The red channel exceeded the service alert limit of +/- 10% with a value of -11.6%, the color chip and the optical surface were cleaned, and the test was performed a second time.The results were improved with a ir1 value of 11.0% which exceeds the service alert limit but not the product specification limit.The red value was -5.7% which was a passing value in all required limits.A lab use only (luo) hematocrit saturation module (h/sat) probe was installed and the monitor powered up normally and passed all monitor start-up checks as expected.After the customer h/sat probe was reinstalled, the monitor was powered up in operate mode.A luo 3/8 inch cuvette was attached and the monitor was left in operate mode with an 84% oxygen saturation (so2) setting for a minimum of eight hours (overnight).After approximately 13 hours, the so2 level had only decreased to 83%.Several in-vivo adjustments were made over approximately the next two hours.All in-vivo adjustments were accepted and reflected properly on the monitor display.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CDI BLOOD PARAMETER MONITORING SYSTEM 500
Type of Device
MONITOR, BLOOD-GAS, ON-LINE, CARDIOPULMONARY BYPASS-CDI BPM SYSTEM 500
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
6200 jackson road
ann arbor MI 48103
MDR Report Key11697597
MDR Text Key247571265
Report Number1828100-2021-00144
Device Sequence Number1
Product Code DRY
UDI-Device Identifier00886799001622
UDI-Public(01)00886799001622(11)120724
Combination Product (y/n)N
PMA/PMN Number
K133658
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup,Followup,Followup
Report Date 09/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/20/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number500AHCT
Device Catalogue Number500AHCT
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/03/2021
Was the Report Sent to FDA? No
Date Manufacturer Received09/17/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-